METTL3 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), METTL3 suppresses SOCS2 expression in a YTHDF2-dependent manner [72], while WTAP reduces ETS1 mRNA levels through the m6A mechanism, collectively promoting cell cycle progression and tumor proliferation [73].